Clinical Trial Update: Impact of Tranexamic Acid Use in Percutaneous Nephrolithotomy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating tranexamic acid to reduce bleeding during percutaneous nephrolithotomy in patients with nephrolithiasis, including those wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis
• Staghorn Calculus

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Sao Paulo | Conditions: Nephrolithiasis, Staghorn Calculus | Phase 4 | Status: UNKNOWN